Nanomedicine (London, England)
An AlFu MOF nanoadjuvant functionalized with mannose for potential dendritic-cell targeting and dual TLR9-STING activation.
Weixia Li, Yang Sun, Yi Guan, Xiao Zhi
Published: 202610.1080/17435889.2026.2614568
Abstract
BACKGROUND: Aluminum adjuvants remain the most widely used adjuvants in licensed vaccines. Their broader application, however, is restricted by local and systemic adverse effects and limited antigen compatibility, slowing vaccine development. METHODS…
Preview only. Read the full abstract at the source